Medexus Pharmaceuticals (TSX:MDP) Growth Rank : 3 (As of Dec. 14, 2024)

View and export this data going back to 2012. Start your Free Trial

What is Medexus Pharmaceuticals Growth Rank?

Medexus Pharmaceuticals has the Growth Rank of 3.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Competitive Comparison of Medexus Pharmaceuticals's Growth Rank

For the Drug Manufacturers - Specialty & Generic subindustry, Medexus Pharmaceuticals's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medexus Pharmaceuticals's Growth Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medexus Pharmaceuticals's Growth Rank distribution charts can be found below:

* The bar in red indicates where Medexus Pharmaceuticals's Growth Rank falls into.

Medexus Pharmaceuticals Growth Rank Related Terms

Thank you for viewing the detailed overview of Medexus Pharmaceuticals's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Medexus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (TSX:MDP) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

MEDXF:USA

Address

10 King Street East, Suite 600, Toronto, ON, CAN, M5C 1C3

Website

https://www.medexus.com

Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions. The company's focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology.

Executives

Brendon Buschman	Senior Officer
Benoit Gravel	Director
Stephen William Nelson	Director
Kenneth D'entremont	Director, Senior Officer
Mike Mueller	Director
Marcel Pascal Konrad	Senior Officer
Brian Peters	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Roland Boivin	Senior Officer
Michael Pine	Senior Officer
Glenn Tate	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Richard Labelle	Senior Officer
Benoît Hébert	Senior Officer